Pulse Biosciences Inc
Chiusa
SettoreSettore sanitario
24.76 -3.73
Panoramica
Variazione del prezzo dell'azione
24h
Minimo
24.76
Massimo
25.84
Entrata | -1.1M -19M |
|---|---|
Vendite | 137K 401K |
EPS | -0.241 |
Margine di Profitto | -4,633.666 |
Dipendenti | 116 |
EBITDA | -1.4M -19M |
Raccomandazioni | Acquista |
|---|---|
Previsioni per 12 mesi | +19.6% upside |
Utili prossimi | 11 ago 2026 |
|---|
Capitalizzazione di Mercato | 179M 1.7B |
|---|---|
Apertura precedente | 28.49 |
Chiusura precedente | 24.76 |
Notizie sul Sentiment di mercato
By Acuity
50%
50%
166 / 342 Classifica in Healthcare
Pulse Biosciences Inc Grafico
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
Chi Siamo Pulse Biosciences Inc
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
